Trial intelligence / Profile preview

NAC Infusion in Liver Procurement

NCT01394497Phase 2Completed

Sponsor
Azienda Ospedaliero-Universitaria di Padova
Start
Dec 2006
Primary completion
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of acetylcysteine in liver failure, hepatocellular carcinoma (HCC), sponsored by Azienda Ospedaliero-Universitaria di Padova. Started Dec 2006; status: completed.

02

Drugs

acetylcysteine
03

Conditions

liver failurehepatocellular carcinoma (HCC)

Beyond the preview

Go deeper on NCT01394497.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01394497.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call